Engine Biosciences
Singapore’s Engine Biosciences secures $27M in Series A extension led by Polaris Partners
Engine Biosciences, a Singapore-based company leveraging machine learning and high-throughput biology to discover and develop precision oncology medicines, has on Wednesday announced the completion of a $27 million Series A extension. The financing was led by Polaris Partners, with participation from both new and existing investors, bringing the total funds…
